Ana Carina Mendes1, Ana-Maria Oros-Peusquens2, André Santos Ribeiro1,3, Karl-Josef Langen2, Carolin Weiß Lucas4, Nadim Jon Shah2, and Hugo Alexandre Ferreira1
1Institute of Biophysics and Biomedical Engineering, Faculty of Sciences of the University of Lisbon, Lisbon, Portugal, 2Forschungszentrum Juelich GmbH, Institute of Neurosciences and Medicine-INM4, Juelich, Germany, 3Centre for Neuropsychopharmacology, Division of Brain Sciences, Department of Medicine, Imperial College London, London, United Kingdom, 4Center of Neurosurgery, University of Cologne, Cologne, Germany
Synopsis
Methods capable of mapping
brain connectivity pathways may prove useful by providing valuable
information in order to prevent sequelae following a surgical
intervention. This study presents an approach for the whole-brain
connectivity evaluation of nine patients with lateralized
gliobastoma, using the Multimodal Imaging Brain Connectivity Analysis
(MIBCA) toolbox to process MR and PET data. Results show changes in
connectivity metrics across both hemispheres for all patients
accompanied by an increased number of fibres which may result from
reorganization of connectivity pathways caused by the disruption of
the original ones by the tumour.Purpose
Planning of surgery involves
the difficult balancing act between removing all areas likely to be
affected by tumour infiltration and preserving function by removing
as little functional tissue as possible.
1
The purpose
of this work was to study the whole-brain connectivity of
glioblastoma patients, paving the way for the development of an
improved connectivity-based pre-surgical planning protocol.
Therefore, the Multimodal Imaging Brain Connectivity Analysis (MIBCA)
toolbox was used.
2Material and methods
Nine
patients with glioblastoma (5 left / 4 right hemisphere, all adjacent
to the primary motor area, Figures 1 and 2) underwent simultaneous
magnetic resonance imaging (MRI) and dynamic
18F-fluoro-ethyl-tyrosine
(
18F-FET)
positron emission tomography (PET) scans. The control group comprised
twenty-two healthy volunteers (only MRI was performed). Imaging data
were acquired on a hybrid MR-PET scanner, consisting of a 3T Siemens
scanner with a BrainPET insert.
3 A birdcage transmit coil and an
8-element receive array were used for radiofrequency transmit and
signal receive, respectively. The MRI protocol
included
volumetric T1-weighted (T1-w) MPRAGE (1x1x1 mm
3),
diffusion tensor imaging (DTI) (dir=30, b-value=800 s/mm
2,
2 averages, 2x2x2 mm
3)
and contrast enhanced volumetric T1-w MPRAGE (1x1x1 mm³) sequences.
The amino acid
18F-FET was produced via nucleophilic
18F-fluorination
with a specific radioactivity of more than 200 GBq/μmol.
4 Time
activity curves of FET uptake were generated and mean and maximum
tumour-to-brain ratios were determined by region-of-interest (ROI)
analysis. Tumour volumes in FET-PET images were calculated from
images containing the integrated intensity (20–60 min) using
threshold-based volume-of-interest analyses that included voxels with
a tumour-to-brain ratio of at least 1.6. This cutoff was based on a
biopsy-controlled study in cerebral gliomas in that a lesion-to-brain
ratio of 1.6 best separated tumour from peritumour tissue.
5
The MIBCA toolbox was used to
automatically pre-process MR-PET data (including brain parcellation)
and to derive imaging and connectivity metrics from the multimodal
data, that is, cortical thickness from contrast enhanced T1-w data;
mean diffusivity (MD), fractional anisotropy (FA), node degree,
clustering coefficient and pairwise ROI fibre tracking from DTI data;
and standardized uptake value (SUV) from PET data. Differences in
whole-brain connectivity between patients and controls were analyzed.
Mean and standard deviation (SD) values were obtained for the control
data, and latter used to threshold patient data in order to constrain
the results to significant differences. To do so, intervals with the
mean and triple SD were obtained in order to threshold patient data
(by verifying which ROIs of each metric fall off the range). Results
were visualized in a connectogram and both structural connectivity
and metrics were studied in regions surrounding lesions (to the
extent of the present oedema), identified by increased uptake in
FET-PET.
Results and Discussion
In Table 1 an overview of the
information obtained from the connectograms concerning the affected
metrics is presented, divided by peritumour and more distant regions.
All patients had regions in which one or more parameters included in
the connectogram deviated by more than 3 SD from the mean value based
on data from healthy volunteers. For most patients, the number of
affected regions is higher in the contralateral, as compared to the
ipsilateral hemisphere. In particular, patient E showed regions with
more than two affected metrics only for non-peritumour regions.
Connectograms with thresholded data can be found in Figures 3 and 4.
Data presented in the connectograms concerning the distribution of
fibres suggest an increase of connections, particularly in the lesion
side, more evident in patients with the tumour in the right
hemisphere (Figure 4, patients G and H).
Findings concerning changes in
metric values, particularly increased FA values, may be related to
fibre packing caused by the tumour mass effect. Changes found in more
distant areas may result from structural re-organization in response
to the presence of the tumour.
Conclusions
The use of multimodal imaging
in this study allows the integration of different type of data that
result in a richer characterization of brain connectivity. Reported
results suggest that tumour infiltration may alter both local and
more distant structural connections.
Future work will focus on the
inclusion of a larger patient group so as to increase robustness of
these findings as well as diffusion kurtosis information to study its
influence on the identification of connectivity changes produced by
tumours.
Ultimately, the goal of the
approach taken in this study is to investigate if and how
connectivity studies can help pre-surgical planning. For instance, by
studying specific brain networks in order to determine the best
anatomical approach to tumour resection and influence the process of
decision-making during surgery, regarding the prevention of sequelae.
Acknowledgements
Research
supported by the Edmond J. Safra Philanthropic Foundation, and by the
Fundação para a Ciência e Tecnologia (FCT) and Ministério da
Ciência e Educação (MCE) Portugal (PIDDAC) under grants
UID/BIO/00645/2013 and PTDC/SAU-ENB/120718/2010.References
1. S. M.
Krieg, J. Sabih, L. Bulubasova, T. Obermueller, C. Negwer, I.
Janssen, E. Shiban, B. Meyer, and F. Ringel, “Preoperative motor
mapping by navigated transcranial magnetic brain stimulation improves
outcome for motor eloquent lesions,” Neuro-Oncology, vol. 16, pp.
1274–1282, Sept. 2014
2. A.
Santos Ribeiro, L. M. Lacerda, and H. A. Ferreira, “Multimodal
Imaging Brain Connectivity Analysis toolbox (MIBCA),” PeerJ
3:e1078, Jul. 2015
3. H.
Herzog, K.-J. Langen, C. Weirich, E. Rota Kops, J. Kaffanke, L.
Tellmann, J. Scheins, I. Neuner, G. Stoffels, K. Fischer, L.
Caldeira, H. H. Coenen, and N. J. Shah, “High resolution BrainPET
combined with simultaneous MRI:,” Nuklearmedizin, vol. 50, no. 2,
pp. 74–82, Feb. 2011
4. K.
Hamacher and H. H. Coenen, “Efficient routine production of the
18f-labelled amino acid O-(2-[18f]fluoroethyl)-l-tyrosine,” Applied
Radiation and Isotopes, vol. 57, pp. 853–856, Dec. 2002
5. D.
Pauleit, F. Floeth, K. Hamacher, M. J. Riemen-schneider, G.
Reifenberger, H.-W. Müller, K. Zilles, H. H. Coenen, and K.-J.
Langen, “O-(2-[18f]fluoroethyl)-l-tyrosine PET combined with MRI
improves the diagnostic assessment of cerebral gliomas,” Brain,
vol. 128, pp. 678–687, Mar. 2005